Dzienis M, Cundom J, Fuentes CS, Spreafico A, et al. Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial. J Clin Oncol 2024 Jul 22:JCO2302625. doi: 10.1200/JCO.23.02625.
PMID: 39038265